34 results about "Eukaryotic organism" patented technology

The invention provides a SpuFz1 variant derived from eukaryotes and application of the SpuFz1 variant in gene editing, particularly provides the SpuFz1 variant and modified omega RNA, and finds that the modified omega RNA and SpuFz1 mutant combination can remarkably improve the editing efficiency and greatly reduce the off-target rate for the first time.

The invention discloses base-modified mRNA (messenger Ribonucleic Acid) and application thereof in a cell-free protein synthesis system, and belongs to the technical field of nucleic acid modification. Natural nucleoside triphosphate is completely replaced by different types of basic group modified nucleoside triphosphate, mRNA with different chemical modifications is obtained through an in-vitro transcription method and purification, and the mRNA is put into an in-vitro cell-free protein synthesis system for reaction. A reaction element recombination system-PURE system based on prokaryote Escherichia coli purified protein and an eukaryote CFPS system taking rabbit reticulated red lysate as a material are mainly selected to detect the corresponding translation efficiency of mRNA modified by different bases in two cell-free protein synthesis systems respectively. Different regulatory activities may be shown in different cell-free protein synthesis systems when different modified nucleotides are doped into mRNA, base modified triphosphoric acid capable of improving the translation efficiency of an in-vitro protein synthesis system is screened out, and the stability of mRNA in the cell-free protein synthesis system and the corresponding protein expression level are improved.

The Quadruplet Expanded DNA (QED) eukaryote genetic code comprising twenty nondegenerate QED codons encode proteins (the protein-encoding codons), and thirty-five nondegenerate QED codons (the noncoding codons) being highly correlated with cis-regulatory elements control and regulate transcription, alternate splicing, and polymerization in eukaryotic protein synthesis using canonical amino acids. The QED eukaryote genetic code is an advancement to gene therapeutics that allows for the correction of dysfunctional proteins. Additionally, the QED eukaryote genetic code is further applicable for changing paradigms relating to identifying cures for monogenic rare, multigene cancer, and neurodegenerative diseases.

An engineered tyrosyl-tRNA synthetase / tRNA pair that co-translationally incorporates O-sulfotyrosine in response to UAG codons in E. coli and mammalian cells is described herein. This platform enables recombinant expression of eukaryotic proteins homogeneously sulfated at chosen sites.

Novel combinations of cysteine-rich insecticidal proteins (CRIPs) and insecticides (IAs), such as chemicals, molecules, nucleotides, polynucleotides, peptides, polypeptides, proteins, toxins, toxic substances, poisons, insecticides, pesticides, organic compounds, inorganic compounds, prokaryotes or eukaryotes (and substances produced from such prokaryotes or eukaryotes), are described and claimed for the control and / or eradication of pests. [Solution] Novel insecticide combinations, compositions, and methods for using them are provided. The present invention relates to a combination of a cysteine-rich insecticide peptide (CRIP) and an insecticide (IA). The present invention also describes the use of the combination and composition for controlling insects. This specification describes the gene encoding CRIP, compositions and combinations containing CRIP and IA, and methods useful for controlling pests using them.

A method for improving the replication of covalent closed circular plasmids is provided. [Solution] The method comprises the step of preparing a covalent closed circular plasmid having a Pol I-dependent origin of replication and an insert containing a structured DNA sequence selected from the group consisting of a reverse repeat sequence, a directional repeat sequence, a homopolymer repeat sequence, a eukaryotic origin of replication, or a eukaryotic promoter enhancer sequence, wherein the structured DNA sequence is located at a distance of less than 1000 bp from the Pol I-dependent origin of replication in the direction of replication. The method also comprises the step of modifying the covalent closed circular recombinant molecule so that the Pol I-dependent origin of replication is replaced with a Pol III-dependent origin of replication, thereby improving the replication of the covalent closed circular plasmid with the resulting Pol III-dependent origin of replication. A covalent closed circular recombinant DNA molecule without antibiotic markers is also provided.

The present invention. relates to a disinfectant composition against parasitic organisms. The invention also relates to a method for disinfecting at least one area to prevent parasitosis. The invention also relates to the use of at least one compound selected from fatty acids and fatty alcohols and which have a chain length of to carbon atoms in a disinfectant composition for improving penetration of active compounds contained in said composition into the durable forms, in particular eggs or oocysts, of parasitic organisms.

The present invention relates to an oligonucleotide comprising: a) a nucleotide sequence of a broom-kojin-ricin loop (SRL) of a eukaryotic / mammalian 60S ribosomal subunit wherein the SRL nucleotide sequence comprises at least one adenine; and b) at least one cut-dependent marker; wherein the oligonucleotide is a single strand. Preferably, the oligonucleotides form at least one loop structure or stem-loop structure. In another aspect, the invention relates to a method of detecting active shiga toxin in a sample, the method comprising the steps of: a) providing at least one oligonucleotide according to the invention; b) providing a sample of shiga toxin to be detected; c) incubating the sample with at least one single-stranded oligonucleotide; and d) detecting a labeled signal, wherein the signal indicates the presence of Shiga toxin in the sample. The invention additionally comprises a kit comprising at least one oligonucleotide according to the invention.

The present invention relates to a disinfectant composition against parasitic organisms. The invention also relates to a method for disinfecting at least one area to prevent parasitosis. The invention also relates to the use of at least one compound selected from fatty acids and fatty alcohols and which have a chain length of 10 to 26 carbon atoms in a disinfectant composition for improving penetration of active compounds contained in said composition into the durable forms, in particular eggs or oocysts, of parasitic organisms.

The present application provides a kind of eukaryotic pan-transcriptome annotation method, comprising the following steps: the transcriptome data of more than 3 different sources of eukaryotic species sample is compared to reference genome, obtains corresponding gene structure annotation information, integrates, obtains the transcriptome annotation result of reference genome dependence;Sample transcriptome data is spliced and assembled, and corresponding mature transcript sequence information is obtained, and the mature transcript sequence information is compared with reference genome, and corresponding gene structure information is obtained, to obtain the transcriptome annotation result of reference genome independence;Integrate structural transcript annotation information, filter transcript that cannot be compared with reference genome, obtain new transcript annotation information;Integrate sample high-throughput transcriptome data, and the pan-transcriptome annotation information of target eukaryotic species can be obtained.The present application can obtain more complete transcriptome annotation structure of eukaryote, and different strategies are mutually verified, which greatly improves the annotation accuracy.

The invention relates to a modular culture system for growing prokaryotic and / or eukaryotic organisms using a nutrient solution (N) for the organisms, wherein the culture system comprises a series of culture modules (100) for receiving the organisms, which culture modules are interconnected to conduct the nutrient solution (N), and an extraction module (200), connected to one of the culture modules (100) for conducting the nutrient solution (N), for the controlled extraction of the nutrient solution (N) from the culture module (100).Each culture module (100) comprises: an outer container (110) through which the nutrient solution (N) flows in a flow direction (S); an inner container (120), located at least partially within the outer container (110), for receiving the organisms; and several connection devices (130) for connecting the outer container (110) to the outer container (110) of an additional culture module (100) and / or to the extraction module (200) for conveying the nutrient solution (N). The inner container (120) is permeable to the nutrient solution (N), and a nutrient chamber (115), through which the nutrient solution (N) flows, is located between the outer container (110) and the inner container (120). The extraction module (200) comprises an extraction control device (240) for controlling the flow of the nutrient solution (N) extracted from the cultivation module (100) by means of the extraction module (200).

The present invention relates to minimal polypeptide-encoding RNA molecules, in particular, RNA molecules that lack or comprise shortened regulatory sequences as compared to those found in eukaryotic mRNAs, which are thus more amenable to chemical synthesis. The invention also encompasses compositions comprising distinct populations of said RNA molecules, each encoding a unique polypeptide, and methods for manufacturing and using the RNA molecules or compositions.

The application discloses an ELISA kit for detecting anti-chromatin antibodies. The kit contains purified chromatin monomers with stripped H1 histone components in a natural structure. The application also discloses a detection method for the ELISA kit. The chromatin structure in the eukaryotic cell nucleus is complex, and is a natural complex composed of 40% DNA, 40% histone, 20% non-histone, a small amount of RNA and other macromolecules. The purification technology is high in requirement, and the price of the natural purified chromatin monomers is high. The application purifies the chromatin monomers with stripped H1 histone components according to the structure of the natural chromatin, retains the effective antigen components, and greatly reduces the cost. The kit can be used for detecting the anti-chromatin antibodies, fills the blank of the domestic anti-chromatin antibody detection method, and has the characteristics of large detection flux, accurate result, high sensitivity and simple operation.

The application provides an RNA framework for gene editing and a gene editing method, the RNA framework comprising a sequence upstream of a target site, a sequence to be inserted, and a sequence downstream of the target site in the 5' to 3' direction. The gene editing method is based on the inherent mechanism of eukaryotes, uses RNP or RNA (which can be prepared in vitro) and related proteins as carriers, and is transferred into the cytoplasm and nucleus to realize gene editing on a specific sequence or site on the genome of a target system, such as insertion, deletion, replacement and site replacement of a specific sequence, and has high targeting accuracy. The application is more suitable for further clinical application than other prior art because no exogenous system or substance such as protein derived from prokaryotes is introduced, and no double-strand break is generated.

The invention relates to the technical field of kits, and discloses a peanut allergen component fluorescence PCR (Polymerase Chain Reaction) detection equivalent kit, which comprises (1) 2 * Probe qPCR Mix; (2) a florescence source probe primer mixture; (3) a 18S internal reference probe primer mixture; (4) ultrapure water; (5) positive control; (6) negative control; according to the invention, a dual detection mechanism of a florescence source specific gene and an eukaryote general reference gene is combined, and a specially designed chimeric recombinant plasmid is adopted as a multifunctional positive control, so that when a complex food matrix is treated, a forced standard reaching mechanism of a reference gene channel can timely identify a sample treatment abnormal condition; and wrong interpretation caused by improper operation is avoided. Meanwhile, the activity of core components of the kit can be verified through the two-channel synchronous response characteristic of positive control, and the credibility of a detection result and the scientific preciseness of interpretation are improved.

Novel insecticidal polypeptides that are active against Coleopteran pests are disclosed. Nucleic acid molecules encoding the novel insecticidal proteins are also provided. The nucleotide sequences encoding the insecticidal polypeptides can be used to transform prokaryotic and eukaryotic organisms to express the insecticidal proteins. Methods of making the insecticidal proteins and methods of using the insecticidal proteins, for example in transgenic plants to confer protection from insect damage are also disclosed.

The invention discloses a method for specifically separating eukaryotic cells from prokaryotic cells in various environments. The invention provides a concanavalin A and magnetic bead complex. The concanavalin A and magnetic bead complex is a complex formed by connecting concanavalin A and magnetic beads, the invention also provides a method for separating eukaryotic cells and prokaryotic cells, which comprises the following steps: adding the concanavalin A and magnetic bead complex into a cell resuspension to be separated, and incubating; and separating the eukaryote cells adsorbed by the magnetic beads from the prokaryote cells not adsorbed by the magnetic beads by using a magnetic frame. The raw materials such as the streptavidin magnetic beads and the concanavalin A involved in the method are low in price and simple to prepare; magnetic separation is utilized, and operation is simple and fast; the separation effect is good.

A method for improving the replication of a covalently closed circular plasmid is provided. The method includes providing a covalently closed circular plasmid having a Pol I-dependent origin of replication, and an insert including a structured DNA sequence selected from inverted repeat sequences, direct repeat sequences, homopolymeric repeat sequences, eukaryotic origins of replication or eukaryotic promoter enhancer sequences, wherein the structured DNA sequence is located at a distance of less than 1000 bp from the Pol I-dependent origin of replication in the direction of replication. The method also includes modifying the covalently closed circular recombinant molecule such that the Pol I-dependent origin of replication is replaced with a Pol III-dependent origin of replication, whereby the resultant Pol III-dependent origin of replication covalently closed circular plasmid has improved replication. An antibiotic marker free covalently closed circular recombinant DNA molecule is also provided.

The present disclosure provides genetically modified heterogametic organism that comprises a genetically modified first sex chromosome comprising at least one exogenous nucleic acid sequence integrated therein. In more specific embodiments, the exogenous nucleic acid sequence comprises (i) at least one nucleic acid sequence encoding at least one nucleic acids modifier component, and further (ii) at least one nucleic acid sequence encoding and / or forming at least one target recognition element for the at least one nucleic acids modifier component of (i). The present disclosure further comprises systems comprising the discussed genetically modified heterogametic organism, methods and uses thereof in biasing sex-ratio of populations.

The invention discloses a benzenesulfonamide triazole derivative as well as a preparation method and application thereof, and is characterized in that the benzenesulfonamide triazole derivative has a structural formula shown as a formula I and a formula II or pharmaceutically acceptable salt, ester or solvate of the benzenesulfonamide triazole derivative with the structural formula shown as the formula I and the formula II, x is a carbonyl group, a sulfonyl group or a sulfuryl group; r1 is o-fluorophenyl, p-trifluoromethoxyphenyl, o-methoxyphenyl, o-methoxyanilino, p-methoxyphenyl, pyrimidine, thiazole, oxazole, methylthiophene, amino and methylamino, and the compound has the advantages that the compound can effectively inhibit CDK, the selectivity to CDK1 is higher than that of other subtype and / or eukaryotic tumor cell proliferation, and tumors are prevented and / or treated.

This invention provides genome editing and genotyping methods using RNA-induced endonucleases (RGENs). [Solution] The present invention relates to targeted genome editing in eukaryotic cells or eukaryotes. More specifically, the present invention relates to a composition for cleaving target DNA in eukaryotic cells or eukaryotes, comprising a guide RNA specific to target DNA and a Cas protein-coding nucleic acid or Cas protein, and the use thereof.

The present disclosure discloses a method for determining NCIN-capped RNA and m7G-capped RNA contained in a sample. The determination method can easily and accurately detect the amount of NCIN-capped RNA and m7G-capped RNA in mRNA of any eukaryote, and the proportion of NCIN-capped RNA and m7G-capped RNA relative to all capped RNA, which helps further research based on the RNA capping condition of the sample.

The invention discloses a traceless induction method of eukaryote polycistron expression ability. The method disclosed by the invention comprises the following steps: introducing an expression cassette into a eukaryotic cell, or introducing a fragment except a promoter in the expression cassette into the downstream of a DNA fragment with promoter activity in the eukaryotic cell, so that the DNA fragment can drive the expression of a gene in the expression cassette to obtain a recombinant biological cell, the expression cassette contains a promoter, an upstream gene, a cistronic interregion and a downstream gene, and 2) carrying out induced culture on the recombinant biological cells by using the selection marker corresponding to the downstream gene to realize the induction of the eucaryon polycistronic expression competence. The method disclosed by the invention can be used for inducing the cells with the polycistronic expression competence in a short time.

The invention belongs to the technical field of biological medicine, a gene editing system MMEJ-Exo is constructed through humanized application of exonuclease or key functional domains derived from microorganisms and eukaryotes, spCas9-mediated eukaryote cells are remarkably improved, especially long-fragment editing of primary neuronal cells is remarkably improved, and the gene editing efficiency is improved. And a new technology and a new method are provided for gene therapy and cell therapy transformation application.

Novel insecticidal polypeptides that are active against lepidopteran insect pests are disclosed. Nucleic acid molecules encoding the novel insecticidal proteins are also provided. The nucleotide sequences encoding the insecticidal polypeptides can be used to transform prokaryotic and eukaryotic organisms to express the insecticidal proteins. Methods of making the insecticidal proteins and methods of using the insecticidal proteins, for example in transgenic plants to confer protection from insect damage, are also disclosed.

The present invention relates to a stable method for introducing at least one inducible cassette into a cell, and allowing controllable transcription from within that inducible cassette; the method can be used for any cell type, from any eukaryotic organism, but has particular application in the introduction of inducible cassettes into pluripotent stem cells, such as animal or human pluripotent stem cells (hPSCs); the inducible cassette is inserted in a controlled manner such that it ensures that the genetic material it contains is not silenced or subjected to adverse influences from the insertion site, and the transcription of the genetic material is controlled.

The invention relates to the technical field of gene codon extension, and particularly provides a modified mitochondrial aminoacyl tRNA synthetase and a gene codon extension system based on the enzyme. The mitochondrial aminoacyl tRNA synthetase and the gene codon extension system can be used for gene codon extension of eukaryotes, and protein expression regulation and control can be carried out in mammalian cells and animal living body levels. Particularly, the gene codon expansion system can ensure orthogonality of the gene codon expansion system used in human cells, also can ensure no immunogenicity, and not only has a wide application prospect, but also has clinical transformation potential.